Use Code: WF26 And Get 30% OFF, T&C Applay | Get Free Delivery With No Minimum Order

Frequently bought together
MUCINEX 600/MG ER TAB 20/TAB
- Sku : I-011755
Key features
MUCINEX 600 mg ER Tablet is an extended-release tablet formulation containing 600 mg of the expectorant guaifenesin. It works by increasing the volume and decreasing the viscosity of respiratory tract secretions, facilitating mucociliary clearance and expectoration. It is indicated for relief of chest congestion by loosening phlegm and thinning bronchial secretions to make coughs more productive. Available by prescription in a pack of 20 extended-release tablets.- Brand: MUCINEX
- Active Ingredient: GUAIFENESIN
- Strength: 600mg
- Dosage Form: Extended-release tablet
- Pack Size: 20 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Respiratory
- Pharmacological Group: Cough & Cold Preparations
- Drug Class: Expectorant.
- Manufacturer: RECKITT BENCKISER HEALTHCARE INTERNATIONAL
- Country of Origin: United Kingdom
- SFDA Registration No.: 0805245258
- Shelf Life: 36 months
- Storage: store below 25°c
- Symptom Target: Congestion, Cough
- Sedating: No
Frequently bought together
Indications
Approved Uses
Relief of chest congestion by loosening phlegm (mucus) and thinning bronchial secretions to make coughs more productive.
Dosage & Administration
Dosing by Condition
Adults and children ≥12 years (extended-release): 600 mg every 12 hours; may increase to 1200 mg every 12 hours if needed; maximum 2400 mg/day.
Initial Dose
600mg every 12 hours (extended-release tablet)
Maintenance Dose
600mg to 1200mg orally every 12 hours.
Maximum Dose
2400mg (2.4g) per 24 hours.
How to Take
Swallow the extended-release tablet whole with a full glass of water; do not crush, chew, or split. Maintain adequate fluid intake to help loosen mucus.
Side Effects
Common Side Effects
Nausea, vomiting, dizziness, headache, and gastrointestinal upset (e.g., stomach pain).
Safety & Warnings
Contraindications
Hypersensitivity to guaifenesin or any component of the formulation.
Warnings & Precautions
Do not use for persistent/chronic cough (e.g., smoking, asthma, chronic bronchitis, emphysema/COPD) or cough with excessive phlegm unless directed by a doctor; consult a doctor if cough lasts >7 days, recurs, or is accompanied by fever, rash, or persistent headache; swallow ER tablets whole (do not crush/chew/break); maintain adequate fluid intake; may interfere with urine lab tests (e.g., 5-HIAA, VMA).
Age Restriction
Not recommended for children under 12 years of age for the 600 mg extended-release tablet.
Driving Warning
No effect on ability to drive or operate machinery
Drug Interactions
Drug Interactions
No clinically significant drug-drug interactions are expected; may interfere with certain urine laboratory tests (e.g., 5-HIAA, VMA) causing false results.
Interaction Severity
No major clinically significant drug-drug interactions are expected; may interfere with certain urine laboratory tests (e.g., 5-HIAA/VMA) causing false results.
Food Interaction
No clinically significant food interaction; may be taken with or without food. Encourage adequate water intake.
Special Populations
Pregnancy
Consult Doctor
Breastfeeding
Consult Doctor
Elderly
Standard adult dosing; ensure adequate hydration
Liver Impairment
No specific dose adjustment recommended; use with caution in significant hepatic impairment due to limited data.
Storage & Patient Advice
Missed Dose
Take as soon as remembered; skip if it is almost time for the next dose. Do not double the dose.
Stopping the Medicine
Safe to stop anytime; no tapering required (typically stop when symptoms resolve).
Patient Counseling
Swallow extended-release tablet whole; do not crush, chew, or split. Take with a full glass of water and maintain adequate hydration to help loosen/thin mucus. Do not exceed labeled maximum: 1200 mg every 12 hours (max 2400 mg/day) unless directed by a clinician. Seek medical advice if cough lasts >7 days, recurs, or is accompanied by fever, rash, or headache.
Monitoring Requirements
No routine monitoring required
Pharmacology
Mechanism of Action
Increases the volume and decreases the viscosity of respiratory tract secretions, facilitating mucociliary clearance and expectoration.
Onset of Action
Approximately 30-60 minutes.
Duration of Effect
Approximately 12 hours (extended-release tablet).
Half-Life
Approximately 1 hour.
Bioavailability
Well absorbed from the gastrointestinal tract after oral administration (absolute bioavailability not well characterized in publicly available labeling).
Metabolism
Hepatic metabolism to inactive metabolites, including beta-(2-methoxyphenoxy) lactic acid.
Excretion
Renal; excreted primarily in urine mainly as inactive metabolites (with a small amount as unchanged drug).
Product Information
Available Dosage Forms
For this PRODUCT: extended-release oral tablet (bi-layer). In general, guaifenesin is also marketed in immediate-release tablets/capsules and oral liquids/solutions/syrups and granules (varies by country/brand).
Composition per Dose
Each extended-release bi-layer tablet: 600mg guaifenesin (immediate-release layer + extended-release layer)
Generic Availability
Yes
OTC Alternatives
OTC guaifenesin immediate-release tablets/capsules (e.g., 200 mg or 400 mg) and OTC guaifenesin oral liquids/syrups (various concentrations), depending on local market.
Symptom Target
Congestion, Cough
Sedating
No
Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 07-07-2026
-1744229570.gif)














